Clinical Trials · NCT06361823
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Capital Medical University
- Enrollment
- 74
- Start date
- May 2024
- Locations
- See registry
- Primary endpoint
- Intracranial pressure